Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Chitra Vinnakota"'
Publikováno v:
Neural Regeneration Research, Vol 15, Iss 6, Pp 1030-1032 (2020)
Externí odkaz:
https://doaj.org/article/440356148d84455b822bef93c898a4a9
Autor:
Patricia Lam, Chitra Vinnakota, Beatriz Calvo-Flores Guzmán, Julia Newland, Katie Peppercorn, Warren P. Tate, Henry J. Waldvogel, Richard L. M. Faull, Andrea Kwakowsky
Publikováno v:
Molecules, Vol 27, Iss 8, p 2440 (2022)
Alzheimer’s disease (AD) is a neurodegenerative disorder with an increasing need for developing disease-modifying treatments as current therapies only provide marginal symptomatic relief. Recent evidence suggests the γ-aminobutyric acid (GABA) neu
Externí odkaz:
https://doaj.org/article/617afa984276461790d793dff686c8c7
Glutamate NMDA receptor (NMDAR) hypofunction has been proposed to underlie schizophrenia symptoms because administration of NMDAR antagonists reproduces behavioral and molecular schizophrenia-like phenotypes in healthy humans and animal models. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::807e9595211f5d47340e32a5af2abd44
https://doi.org/10.20944/preprints202305.1068.v1
https://doi.org/10.20944/preprints202305.1068.v1
Autor:
Daniel Bennett, Jay Nakamura, Chitra Vinnakota, Elysia Sokolenko, Jess Nithianantharajah, Maarten van den Buuse, Nigel C. Jones, Suresh Sundram, Rachel Hill
The trial-unique non-matching to location (TUNL) touchscreen task shows promise as a translational assay of working memory deficits in disorders including autism, ADHD, and schizophrenia. Although it is commonly assumed that the TUNL task predominant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1598bb59867398d1419ebd06ea0a3bd4
https://doi.org/10.1101/2022.10.30.514444
https://doi.org/10.1101/2022.10.30.514444
Autor:
Patricia, Lam, Chitra, Vinnakota, Beatriz Calvo-Flores, Guzmán, Julia, Newland, Katie, Peppercorn, Warren P, Tate, Henry J, Waldvogel, Richard L M, Faull, Andrea, Kwakowsky
Publikováno v:
Molecules (Basel, Switzerland). 27(8)
Alzheimer's disease (AD) is a neurodegenerative disorder with an increasing need for developing disease-modifying treatments as current therapies only provide marginal symptomatic relief. Recent evidence suggests the γ-aminobutyric acid (GABA) neuro
Publikováno v:
Neural Regeneration Research, Vol 15, Iss 6, Pp 1030-1032 (2020)
Neural Regeneration Research
Neural Regeneration Research
Publikováno v:
Systems Biology in Reproductive Medicine. 65:451-457
Sperm DNA integrity is important for fertility, however the incidence of high levels of DNA fragmentation (DNA fragmentation index (DFI)30%) is not well described. In 2011, our clinics implemented guidelines for sperm DNA fragmentation (SDF) testing
Autor:
Chitra Vinnakota, Richard L.M. Faull, Karan Govindpani, Henry J. Waldvogel, Andrea Kwakowsky, Beatriz Calvo-Flores Guzmán
Publikováno v:
Journal of Neurochemistry. 146:649-669
Glutamatergic and cholinergic dysfunction are well-attested features of Alzheimer's disease (AD), progressing with other pathological indices of the disorder and exacerbating neuronal and network dysfunction. However, relatively little attention has
Autor:
Laura G McNamara, Richard L.M. Faull, Karan Govindpani, Chitra Vinnakota, Andrea Kwakowsky, Nicholas R Smith, Henry J Waldvogel
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 5, p 651 (2019)
Journal of Clinical Medicine
Journal of Clinical Medicine
Alzheimer’s disease (AD) is the most prevalent form of dementia. Despite decades of research following several theoretical and clinical lines, all existing treatments for the disorder are purely symptomatic. AD research has traditionally been focus
Autor:
Richard L.M. Faull, Karan Govindpani, Andrea Kwakowsky, Beatriz Calvo-Flores Guzmán, Henry J. Waldvogel, Chitra Vinnakota
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 8, p 1813 (2017)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
γ-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the vertebrate brain. In the past, there has been a major research drive focused on the dysfunction of the glutamatergic and cholinergic neurotransmitter systems in Alzheimer